Background. Many of the therapeutic proposals for COVID-19 have been associated with adverse effects, including the risk of QT interval prolongation and torsades de pointes (TdP). The objective was to determine the use of drugs with a risk of QT interv
Uso de medicamentos asociados con prolongación del intervalo QT en hospitales de Colombia durante la Pandemia de Covid19
Audifarma |
| Tiempo de lectura: Min
- Tema: farmacoepidemiología
- Autores: Andrés Gaviria-Mendoza,1,2Manuel Enrique Machado-Duque,1,2Luis Fernando Valladales-Restrepo,1,2Carlos Fernando Tovar-Yepes,1and Jorge Enrique Machado-Alba
- Idiomas: Inglés
- Palabras clave: COVID-19; Drug-related side effects and adverse reactions; Hospitals; Hydroxychloroquine; Long QT syndrome; Pharmacovigilance; Severe acute respiratory syndrome coronavirus 2; Torsades de Pointes
Andrés Gaviria-Mendoza, Manuel Enrique Machado-Duque, Luis Fernando Valladales-Restrepo, Carlos Fernando Tovar-Yepes, Jorge Enrique Machado-Alba, "Use of Drugs Associated with QT Interval Prolongation at the Hospital Level during the COVID-19 Pandemic in Enlace: https://doi.org/10.1155/2022/3045942